The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study

Autoimmunity Reviews

Volumn 14, Issue 6, 2015, Pages 498-502

  Mekinian, Arsène ^a   Lazzaroni, Maria Grazia ^b   Kuzenko, Anna ^c   Alijotas Reig, Jaume ^d   Ruffatti, Amelia ^e   Levy, Pierre ^f,g,h   Canti, Valentina ⁱ   Bremme, Katarina ^j   Bezanahary, Holy ^k,l   Bertero, Tiziana ^c   Dhote, Robin ^m,n   Maurier, Francois ^o   Andreoli, Laura ^b   Benbara, Amélie ^m,p   Tigazin, Ahmed ^m,p   Carbillon, Lionel ^m,p   Nicaise Roland, Pascale ^q   Tincani, Angela ^b   Fain, Olivier ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SPEDALI CIVILI   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSITY OF PADOVA   (Italy)

^f Hôpitaux Universitaires de l Est Parisien   (France)

^g INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

^j KAROLINSKA INSTITUTE   (Sweden)

^k UNIVERSITY OF LIMOGES   (France)

^l LIMOGES UNIVERSITY HOSPITAL   (France)

^m UNIVERSITÉ PARIS 13   (France)

ⁿ AVICENNE HOSPITAL   (France)

^o Service de médecine interne et rhumatologie   (France)

^p HÔPITAL JEAN VERDIER   (France)

^q BICHAT HOSPITAL   (France)

more..

Author keywords

Hydroxychloroquine; Obstetrical antiphospholipid syndrome; Outcome

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PREDNISONE; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS DEATH; FETUS WASTAGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; RETROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SPONTANEOUS ABORTION; THROMBOSIS; IMMUNOLOGY; MULTICENTER STUDY (TOPIC);

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MULTICENTER STUDIES AS TOPIC; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84933670410     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.01.012     Document Type: Review

References (22)

1. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4(2):295-306.
2. Ruiz-Irastorza G., Crowther M., Branch W., Khamashta M.A. Antiphospholipid syndrome. Lancet 2010, 376(9751):1498-1509.
3. Comarmond C., Cacoub P. Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies. Autoimmun Rev 2013, 12(7):752-757.
4. Mekinian A., Costedoat-Chalumeau N., Masseau A., Tincani A., De Caroli S., Alijotas-Reig J., et al. Is there a place for hydroxychloroquine to improve the pregnancy outcome?. Autoimmun Rev 2015, 14(1):23-29.
5. Alijotas-Reig J., Ferrer-Oliveras R., Ruffatti A., Tincani A., Lefkou E., Bertero M.T., et al. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases. Autoimmun Rev 2015, 14(5):387-395.
6. Alijotas-Reig J. Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management. Lupus 2013, 22(1):6-17.
7. J. Alijotas-Reig, R. Ferrer-Oliveras. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report. Lupus.21(7):766-768.
8. Mekinian A., Lachassinne E., Nicaise-Roland P., Carbillon L., Motta M., Vicaut E., et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis 2013, 72(2):217-222.
9. Ruffatti A., Salvan E., Del Ross T., Gerosa M., Andreoli L., Maina A., et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost 2014, 112(4):727-735.
10. Schmidt-Tanguy A., Voswinkel J., Henrion D., Subra J., Loufrani L., Rohmer V., et al. Anti-thrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients. J Thromb Haemost 2013, 11(10):1927-1929.
11. Wu X.X., Guller S., Rand J.H. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression. Am J Obstet Gynecol 2011, 205(6). [576 e577-514].
12. Ruffatti A., Marson P., Pengo V., Favaro M., Tonello M., Bortolati M., et al. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmun Rev 2007, 6(3):196-202.
13. C.R. Albert, W.J. Schlesinger, C.A. Viall, M.J. Mulla, J.J. Brosens, L.W. Chamley, V.M. Abrahams. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function. Am J Reprod Immunol.71(2):154-164.
14. Marchetti T, Ruffatti A, Wuillemin C, de Moerloose P, Cohen M. Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies. J Thromb Haemost.12(6):910-920.
15. Erkan D., Lockshin M.D. APS ACTION-AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. Lupus 2012, 21(7):695-698.
16. Erkan D., Aguiar C.L., Andrade D., Cohen H., Cuadrado M.J., Danowski A., et al. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 2015, 13(6):685-696.
17. Bramham K., Thomas M., Nelson-Piercy C., Khamashta M., Hunt B.J. First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood 2011, 117(25):6948-6951.
18. Lockshin M.D., Kim M., Laskin C.A., Guerra M., Branch D.W., Merrill J., et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012, 64(7):2311-2318.
19. Ruffatti A. Treatment Strategy and Pregnancy Outcome in Antiphospholipid Syndrome Patients With Thrombosis and Triple Antiphospholipid Positivity 2013.
20. Ruffatti A, Calligaro A, Hoxha A, Trevisanuto D, Ruffatti AT, Gervasi MT, Cuffaro S, Pengo V, Punzi L. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res (Hoboken).62(3):302-307.
21. Ruffatti A., Tonello M., Visentin M.S., Bontadi A., Hoxha A., De Carolis S., et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 2011, 50(9):1684-1689.
22. Bramham K., Hunt B.J., Germain S., Calatayud I., Khamashta M., Bewley S., et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 2010, 19(1):58-64.